PER 1.25% 7.9¢ percheron therapeutics limited

For General Information, page-2802

  1. 863 Posts.
    lightbulb Created with Sketch. 830
    Totally agree Dalts.
    Many are unaware of how an R&D biotech evolves.
    Diamond and the other Directors were the people who created ANP, that managed it to weather the financial storm whilst development occurred and that pushed for the pathways that have got it here to where we are now, and that got Charmaine and pretty much everyone else here.
    Quite possibly the only person that's here now who may not have been by Diamond's hand, is JG, but we don't know, he may have been involved in that also as a Director.
    And people don't seem to understand transition and roles.
    It is all speculative, but Diamond wasn't as charismatic an orator as JG, that is clear, but Diamond's role and skills were to create and grow a company to the stage where we needed a new CEO, who had more of a gift of the **, and more medical knowledge to draw on.
    It's quite possible if Garner or a similar CEO was in place 20+ years ago, that we might not exist today.
    Garner's skillset is suited to this stage of pre/commercial growth and Diamonds was to create and grow, and most importantly, exist.
    It can be quite petty and also naive when people bitch about the people that got us to where we are.
    Appreciation isn't the first, or last thing that comes to some people's minds.
    Instead of whining people should be saying 'thanks for getting us here mate, it's appreciated'.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.9¢
Change
-0.001(1.25%)
Mkt cap ! $83.73M
Open High Low Value Volume
8.1¢ 8.2¢ 7.9¢ $153.8K 1.914M

Buyers (Bids)

No. Vol. Price($)
12 927041 7.9¢
 

Sellers (Offers)

Price($) Vol. No.
8.1¢ 218878 1
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.